REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Fusion prostate biopsy – smart test for prostate cancer now available at Sheba

fusion prostate biopsy

A prostate biopsy is recommended in case of suspected prostate cancer due to increased PSA levels or an abnormal rectal examination, or both.

A fusion biopsy is a smart biopsy guided by MRI scanning. During the test, suspicious areas are noted by the radiologist, and the MRI data is combined with ultrasound images. This combination (fusion) makes it possible to target the biopsy more accurately to suspicious areas, rather than blind piercing, and to increase the rate of disease detection.

The biopsy is managed by a urologist, who takes a small tissue sample from the prostate using a small needle. Then, a tissue sample is sent to the pathological laboratory for microscopic examination.

Who should undergo a fusion biopsy?

Leading HMOs in the United States and Europe recommend to undergo an MRI-guided biopsy in all cases where a re-biopsy is necessary. It means that the patient has already undergone a prostate biopsy with normal results, but it is necessary to repeat the procedure because of the alleged disease or in case of follow-up. Patients with an enlarged prostate or with a high suspicion of cancer who have not previously undergone a prostate biopsy can also use this method.

Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More